Mitochondrial alterations and tendency to apoptosis in peripheral blood cells from children with Down syndrome

FEBS Letters

Volumn 581, Issue 3, 2007, Pages 521-525

  Roat, Erika ^a   Prada, Nicole ^a,b   Ferraresi, Roberta ^a   Giovenzana, Chiara ^a   Nasi, Milena ^a   Troiano, Leonarda ^a   Pinti, Marcello ^a   Nemes, Elisa ^a   Lugli, Enrico ^a   Biagioni, Ornella ^c   Mariotti, Mauro ^c   Ciacci, Luigi ^a   Consolo, Ugo ^a   Balli, Fiorella ^a   Cossarizza, Andrea ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c AUSL Modena   (Italy)

Author keywords

Apoptosis; Down syndrome; Mitochondria; mtDNA

Indexed keywords

MITOCHONDRIAL DNA;

ADOLESCENT; APOPTOSIS; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA CONTENT; DOWN SYNDROME; FEMALE; HUMAN; HUMAN CELL; MALE; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL MEMBRANE POTENTIAL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RESPIRATORY CHAIN;

ADOLESCENT; APOPTOSIS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DNA, MITOCHONDRIAL; DOWN SYNDROME; FEMALE; HUMANS; INFANT; LEUKOCYTES, MONONUCLEAR; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA;

EID: 33846483260     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.12.058     Document Type: Article

References (28)

1. Baird P.A., and Sadovnick A.D. Life tables for Down syndrome. Hum. Genet. 82 (1989) 291-292
2. Fong C.T., and Brodeur G.M. Down's syndrome and leukemia: epidemiology, genetics, cytogenetics and mechanisms of leukemogenesis. Cancer Genet. Cytogenet. 28 (1987) 55-76
3. Prada N., Nasi M., Troiano L., Roat E., Pinti M., Nemes E., Lugli E., Ferraresi R., Ciacci L., Bretoni D., Biagioni O., Gibertoni M., Cornia C., Meschiari L., Gramazio E., Mariotti M., Consolo U., Balli F., and Cossarizza A. Direct analysis of thymic function in children with Down's syndrome. Immun. Ageing 2 (2005) 4
4. Navarro C.L., Cau P., and Levy N. Molecular bases of progeroid syndromes. Hum. Mol. Genet. 15 Spec No 2 Spec No 2 (2006) R151-R161
5. Busciglio J., and Yankner B.A. Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature 378 (1995) 776-779
6. Teipel S.J., and Hampel H. Neuroanatomy of Down syndrome in vivo: a model of preclinical Alzheimer's disease. Behav. Genet. 36 (2006) 405-415
7. Chen Y.Z. APP induces neuronal apoptosis through APP-BP1-mediated downregulation of beta-catenin. Apoptosis 9 (2004) 415-422
8. Helguera P., Pelsman A., Pigino G., Wolvetang E., Head E., and Busciglio J. Ets-2 promotes the activation of a mitochondrial death pathway in Down's syndrome neurons. J. Neurosci. 25 (2005) 2295-2303
9. Zeviani M., and Antozzi C. Mitochondrial disorders. Mol. Hum. Reprod. 3 (1997) 133-148
10. Druzhyna N., Nair R.G., LeDoux S.P., and Wilson G.L. Defective repair of oxidative damage in mitochondrial DNA in Down's syndrome. Mutat. Res. 409 (1998) 81-89
11. Lee H.C., Yin P.H., Lu C.Y., Chi C.W., and Wei Y.H. Increase of mitochondria and mitochondrial DNA in response to oxidative stress in human cells. Biochem. J. 348 Pt 2 (2000) 425-432
12. Lenaz G., Baracca A., Fato R., Genova M.L., and Solaini G. New insights into structure and function of mitochondria and their role in aging and disease. Antioxid. Redox. Signal. 8 (2006) 417-437
13. Lee S.H., Lee S., Jun H.S., Jeong H.J., Cha W.T., Cho Y.S., Kim J.H., Ku S.Y., and Cha K.Y. Expression of the mitochondrial ATPase6 gene and Tfam in Down syndrome. Mol. Cells 15 (2003) 181-185
14. Hamurcu Z.D.H., Patiroglu T., Kumandas S., Imamoglu N., Ozkul Y., and Donmez-Altuntas H. Age-dependent decreases in mitogen-stimulation level and RNA content in peripheral blood mononuclear cells of down syndrome patients. Cytometry B Clin. Cytom. (2006)
15. Gerez L., Madar L., Arad G., Sharav T., Reshef A., Ketzinel M., Sayar D., Silberberg C., and Kaempfer R. Aberrant regulation of interleukin-2 but not of interferon-gamma gene expression in Down syndrome (trisomy 21). Clin. Immunol. Immunopathol. 58 (1991) 251-266
16. Park E., Alberti J., Mehta P., Dalton A., Sersen E., and Schuller-Levis G. Partial impairment of immune functions in peripheral blood leukocytes from aged men with Down's syndrome. Clin. Immunol. 95 (2000) 62-69
17. Cossarizza A., Baccarani-Contri M., Kalashnikova G., and Franceschi C. A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5′,6,6′-tetrachloro-1,1′,3,3′- tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochem. Biophys. Res. Commun. 197 (1993) 40-45
18. Shapiro H.M. Pratical Flow Cytometry (1995), Wiley-Liss, New York
19. Mussini C., Pinti M., Bugarini R., Borghi V., Nasi M., Nemes E., Troiano L., Guaraldi G., Bedini A., Sabin C., Esposito R., and Cossarizza A. Effect of treatment interruption monitored by CD4 cell count on mitochondrial DNA content in HIV-infected patients: a prospective study. Aids 19 (2005) 1627-1633
20. Mann D.M., Yates P.O., Marcyniuk B., and Ravindra C.R. Pathological evidence for neurotransmitter deficits in Down's syndrome of middle age. J. Ment. Defic. Res. 29 Pt 2 (1985) 125-135
21. Tanzi R.E., Gusella J.F., Watkins P.C., Bruns G.A., George-Hyslop P.St., Van Keuren M.L., Patterson D., Pagan S., Kurnit D.M., and Neve R.L. Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science 235 (1987) 880-884
22. Cossarizza A., Monti D., Montagnani G., Ortolani C., Masi M., Zannotti M., and Franceschi C. Precocious aging of the immune system in Down syndrome: alteration of B lymphocytes, T-lymphocyte subsets, and cells with natural killer markers. Am. J. Med. Genet. Suppl. 7 (1990) 213-218
23. Cossarizza A., Ortolani C., Forti E., Montagnani G., Paganelli R., Zannotti M., Marini M., Monti D., and Franceschi C. Age-related expansion of functionally inefficient cells with markers of natural killer activity in Down's syndrome. Blood 77 (1991) 1263-1270
24. Satge D., Sommelet D., Geneix A., Nishi M., Malet P., and Vekemans M. A tumor profile in Down syndrome. Am. J. Med. Genet. 78 (1998) 207-216
25. Goldacre M.J., Wotton C.J., Seagroatt V., and Yeates D. Cancers and immune related diseases associated with Down's syndrome: a record linkage study. Arch. Dis. Child. 89 (2004) 1014-1017
26. Lee T.J., Kim O.H., Kim Y.H., Lim J.H., Kim S., Park J.W., and Kwon T.K. Quercetin arrests G2/M phase and induces caspase-dependent cell death in U937 cells. Cancer Lett. 240 (2006) 234-242
27. Lugli E., Troiano L., Ferraresi R., Roat E., Prada N., Nasi M., Pinti M., Cooper E.L., and Cossarizza A. Characterization of cells with different mitochondrial membrane potential during apoptosis. Cytometry A 68 (2005) 28-35
28. Busciglio J., Pelsman A., Wong C., Pigino G., Yuan M., Mori H., and Yankner B.A. Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down's syndrome. Neuron 33 (2002) 677-688